Search results for "ALZHEIMER"

showing 10 items of 706 documents

Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases.

2008

The receptor for advanced glycation end products (RAGE) is a 55-kDa type I membrane glycoprotein of the immunoglobulin superfamily. Ligand-induced up-regulation of RAGE is involved in various pathophysiological processes, including late diabetic complications and Alzheimer disease. Application of recombinant soluble RAGE has been shown to block RAGE-mediated pathophysiological conditions. After expression of full-length RAGE in HEK cells we identified a 48-kDa soluble RAGE form (sRAGE) in the culture medium. This variant of RAGE is smaller than a 51-kDa soluble version derived from alternative splicing. The release of sRAGE can be induced by the phorbol ester PMA and the calcium ionophore c…

endocrine system diseasesADAM10Receptor for Advanced Glycation End ProductsMatrix Metalloproteinase InhibitorsHydroxamic AcidsBiochemistryProtein biotinylationCell LineDiabetes ComplicationsADAM10 ProteinGlycationAlzheimer DiseaseHumansProtein IsoformsProtease Inhibitorscardiovascular diseasesRNA Small InterferingReceptors ImmunologicReceptorMolecular BiologyProtein kinase CCalcimycinIonophoresChemistryHEK 293 cellsCell Membranenutritional and metabolic diseasesMembrane ProteinsCell BiologyProtein Structure TertiaryADAM ProteinsAlternative SplicingEctodomainBiochemistryMatrix Metalloproteinase 9cardiovascular systemCarcinogensImmunoglobulin superfamilyTetradecanoylphorbol AcetateAmyloid Precursor Protein Secretaseshuman activitiesThe Journal of biological chemistry
researchProduct

Dementia : hoitajien käsityksiä dementiahoidosta hoitokodeissa ja erityishoitoyksiköissä

1999

erityishoitoyksiköthoitokoditAlzheimerin tautidementia
researchProduct

El papel del ejercicio físico en la inducción de BDNF y sus vías de señalización en el sistema nervioso central. Aplicación neurobiológica en modelos…

2014

La actividad física previene numerosas patologías y mejora muchos rasgos fisiopatológicos en diferentes enfermedades. El ejercicio ha sido asociado clásicamente con beneficios en desórdenes musculares y metabólicos. Sin embargo, los efectos del ejercicio en la función cerebral, especialidad conocida como “Neurobiología del ejercicio”, han cobrado gran importancia en los últimos años. Los efectos beneficiosos del ejercicio físico han sido establecidos en muchas enfermedades tales como la enfermedad de Alzheimer, el Parkinson, la esclerosis lateral amiotrófica, la esquizofrenia, el trastorno bipolar y los trastornos depresivos, entre otros. Estos hallazgos han llevado a utilizar el ejercicio …

factor neurotrófico derivado del cerebroentrenamiento físicoenfermedad de alzheimerUNESCO::CIENCIAS MÉDICASneuroplasticidad:CIENCIAS MÉDICAS [UNESCO]neurodegeneración
researchProduct

Impact of an olfactory priming on food intake: a case study in an Alzheimer's Unit

2014

Impact of an olfactory priming on food intake: a case study in an Alzheimer's Unit. 6. european conference on sensory and consumer research: a sense of life

food intake[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutritionalzheimernutritional deficiencymalnutritionmaison de retraiteelderlyaliment pour personne agée[SDV.AEN] Life Sciences [q-bio]/Food and Nutritionnursing homenutritionold age homespriming[SDV.AEN]Life Sciences [q-bio]/Food and Nutritionapport alimentaire
researchProduct

Characterization of Epileptic Spiking Associated With Brain Amyloidosis in APP/PS1 Mice

2019

Epileptic activity without visible convulsions is common in Alzheimer’s disease (AD) and may contribute adversely to the disease progress and symptoms. Transgenic mice with amyloid plaque pathology also display epileptic seizures, but those are too infrequent to assess the effect of anti-epileptic treatments. Besides spontaneous seizures, these mice also display frequent epileptic spiking in epidural EEG recordings, and these have provided a means to test potential drug treatment to AD-related epilepsy. However, the origin of EEG spikes in transgenic AD model mice has remained elusive, which makes it difficult to relate electrophysiology with underlying pathology at the cellular and molecul…

hippocampusamyloidoosiAlzheimer's diseaseAlzheimerin tautilcsh:RC346-429uni (lepotila)amyloid - beta- proteinaivokuoricortexNeurologymental disordersepilepsyNeurology (clinical)hippokampusEEGsleepepilepsialcsh:Neurology. Diseases of the nervous systemOriginal ResearchtransgenicFrontiers in Neurology
researchProduct

Kokemuksia muistin heikkenemisestä : "Ku ei elä ennää siinä muistossa, että niinku sitä ol terävä"

2002

ikääntyminenmuistihäiriötmuistiAlzheimerin tautidementia
researchProduct

Classification of healthy, Alzheimer and Parkinson populations with a multi-branch neural network

2022

Signal processing, for delimitation of the target events and parametrization, is usually required when instrumented assessment is conducted to determine an individual’s functional status. However, these procedures may rule out relevant information obtained by sensors. To prevent this, the use of models based on neural networks that automatically extract relevant features from the raw signal may improve the characterization of the functional status. Thus, the aim of the study was to determine the classification accuracy of a multi-head convolutional layered neural network (CNN) using a simple functional mobility test in people with different conditions. The raw data from an inertial sensor e…

inertial sensorparkinson’s diseaseSignal Processingalzheimer diseaseBiomedical EngineeringHealth Informaticsfunctional assessmentmulti-branch convolutional classifierUNESCO::CIENCIAS TECNOLÓGICASBiomedical Signal Processing and Control
researchProduct

Biodistribution of Insulin-Nanogels in Mouse: A Preliminary Study for the Treatment of Alzheimer's Disease

2017

A growing body of evidence shows that Insulin, Insulin Receptor (IR) and IR signaling are involved in brain cognitive functions and their dysfunction is implicated in Alzheimer's disease (AD) neurodegeneration. Thus, administration of insulin could be a strategy for AD treatment. For this aim we have designed, synthesized and characterized a nanogel system (NG) that has been conjugated to insulin molecules (NG-In) to deliver the protein into the brain, as a tool for the development of a new therapy against AD. In our preclinical study in mice, intraperitoneal injection of fluorescent-labeled NG has allowed to determine the biodistribution of NG vs time in the whole body and its clearance th…

insulinBiodistributionmedicine.medical_treatmentIntraperitoneal injectionBiophysics02 engineering and technologyPharmacology010402 general chemistrySettore BIO/09 - Fisiologia01 natural sciencesintranasal administrationnanogelsTreatment of Alzheimer's DiseasemedicineDistribution (pharmacology)biologybusiness.industryInsulinNeurodegeneration021001 nanoscience & nanotechnologymedicine.diseaseSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)0104 chemical sciencesInsulin receptorImmunologybiology.proteinNasal administrationSettore CHIM/07 - Fondamenti Chimici Delle TecnologieAlzheimer disease0210 nano-technologybusinessNanogelBiophysical Journal
researchProduct

Muistihäiriöpotilaat ajokyvyn arvioijina : itsearvioinnin luotettavuus ajokykytutkimuksessa

2007

itsearviointimuistihäiriötajokykyAlzheimerin tauti
researchProduct

Ajokyvyn arviointi MoCA-menetelmällä Alzheimerin taudin varhaisvaiheessa

2019

Vertaisarvioitu Lähtökohdat Tutkimme Montreal Cognitive Assessment (MoCA) -menetelmän soveltuvuutta varhaista Alzheimerin tautia sairastavien potilaiden ajokyvyn arviointiin. Selvitimme myös menetelmän herkkyyttä tunnistaa kognitiomuutoksia. Menetelmät Tutkimus sisälsi haastattelun, kognitiivisen arvioinnin (MoCA), ajon simulaattorilla ja oman ajamisen arvioinnin. Siihen osallistui 7 potilasta ja 17 tervettä ikätoveria. Tulokset Potilaat suoriutuivat verrokkeja heikommin MoCA-testissä ja simulaattoriajossa. Arvio omasta suoriutumisesta ajossa oli heillä merkitsevästi parempi kuin verrokeilla. Potilaat saivat testipisteitä keskimäärin 18,6 ja verrokit 27,4. Simulaattoriajossa potilaat tekivä…

kognitioMemory DisordersAutomobile DrivingmuistisairaudetpäätöksentekoajokykylääketiedepäätöksetMental Status and Dementia TestsAlzheimerin tautisairaudentuntoharkintakykyAlzheimer DiseasehavainnointiCognitive DysfunctionliikenneturvallisuusvalinnatCognition DisordersMontreal Cognitive Assessment (MoCA)diagnoosi3112 Neurotieteetterveystunnistaminen3124 Neurologia ja psykiatria
researchProduct